Maintenance of treatment gains up to 12-months following a three-week cognitive processing therapy-based intensive PTSD treatment programme for veterans. Issue 1 (31st December 2020)

• Record Type: Journal Article
• Authors: Held, Philip; Zalta, Alyson K.; Smith, Dale L.; Bagley, Jenna M.; Steigerwald, Victoria L.; Boley, Randy A.; Miller, Michelle; Brennan, Michael B.; Van Horn, Rebecca; Pollack, Mark H.
• Is Part Of: European journal of psychotraumatology. Volume 11:Issue 1(2020)
• Publication Date: 2020-12-31
• Subjects: PTSD -- intensive treatment -- veterans -- follow-up -- posttraumatic cognitions; PTSD -- 强化治疗 -- 退伍军人 -- 随访 -- 创伤后认知; TEPT -- tratamiento intensivo -- veteranos -- seguimiento -- cogniciones postraumáticas; Intensive treatment programmes (ITPs) deliver treatment over the course of 1-3 weeks and show promise for reducing PTSD and depression symptoms. This study showed that symptom reductions achieved during an ITP can be maintained for up to 12 months after treatment completion; Post-traumatic stress disorder -- Periodicals; Stress Disorders, Post-Traumatic; Post-traumatic stress disorder; Electronic journals; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 616.8521
• DOI: 10.1080/20008198.2020.1789324
• Languages: English
• ISSNs: 2000-8198

Abstract

ABSTRACT: Background: Intensive treatment programmes (ITPs) have shown promise for reducing PTSD and depression symptoms. It is still unknown whether treatment gains are maintained following completion. Objective: This study examined whether veterans were able to maintain treatment gains for up to 12 months after an ITP for PTSD and whether reductions in negative posttrauma cognitions predicted treatment gain maintenance. Methods: 209 veterans (62.7% male, mean age = 40.86 years) completed a 3-week, CPT-based ITP for PTSD. Participants' PTSD (PCL-5) and depression (PHQ-9) symptoms were assessed at pre-treatment, post-treatment, and at 3-, 6-, and 12-month follow-up timepoints. Results: Despite small symptom increases from post-treatment to 3-month follow-up, significant and clinically meaningful reductions in PTSD and depression symptoms were reported from intake to 12 months follow-up (averaging >18 points on the PCL-5 and >6 points on the PHQ-9; d = 1.28, and d = 1.18, respectively). Greater reductions in negative posttrauma cognitions during treatment were associated with lower PTSD ( p <.001) and depression ( p =.005) severity at follow-up. Most veterans who completed the aftercare survey followed treatment recommendations and reported seeing a mental health provider at 3-, 6-, and 12-months post-treatment. Aftercare treatment did not significantly predict whether veterans maintained treatment gains at follow-up. Conclusions: Overall maintenance of treatment gains long-term suggests veterans may be able to apply skills acquired during the ITP following treatment. These findings further support the feasibility and effectiveness of intensive, trauma-focused, evidence-based therapy delivery.